Continuous Supraglottic Aspiration in Intubated and Mechanically Ventilated Patients: the "SUPRAtube" Device
Supratube
Evaluation of the Effectiveness and Safety of an Own-invention System for Continuous Supraglottic Aspiration in Intubated and Mechanically Ventilated Patients: the "SUPRAtube" Device
1 other identifier
interventional
38
1 country
1
Brief Summary
Purpose of the trial: Evaluate the efficacy and safety of the device of self-invention of continuous oropharyngeal aspiration denominated "SUPRAtube" in patients with orotracheal intubation and mechanical ventilation.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jan 2016
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 10, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 12, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
December 20, 2017
CompletedFirst Submitted
Initial submission to the registry
May 31, 2018
CompletedFirst Posted
Study publicly available on registry
June 29, 2018
CompletedJuly 10, 2018
July 1, 2018
1.9 years
May 31, 2018
July 9, 2018
Conditions
Outcome Measures
Primary Outcomes (1)
aspirated secretions
volume of aspirated secretions
24 hours after intubation
Secondary Outcomes (1)
Adverse events
24 hours after intubation
Study Arms (1)
Supratube
OTHERPatient with orotracheal intubation and supratube device
Interventions
Eligibility Criteria
You may qualify if:
- Endotracheal intubation and invasive mechanical ventilation,
You may not qualify if:
- Immediate postoperative oral cavity.
- Traumatic oral cavity injury.
- Platelet count less than 50000.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Fundación Cardiovascular de Colombia
Piedecuesta, Santander Department, 681011, Colombia
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 31, 2018
First Posted
June 29, 2018
Study Start
January 10, 2016
Primary Completion
December 12, 2017
Study Completion
December 20, 2017
Last Updated
July 10, 2018
Record last verified: 2018-07